METROPOLITAN LIFE INSURANCE CO/NY - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,761
-36.2%
4,3410.0%0.00%0.0%
Q2 2023$21,575
+0.6%
4,3410.0%0.00%0.0%
Q1 2023$21,445
-40.4%
4,341
-24.1%
0.00%
-50.0%
Q4 2022$35,973
-24.9%
5,719
+29.0%
0.00%0.0%
Q3 2022$47,876
-5.3%
4,4330.0%0.00%0.0%
Q2 2022$50,536
+25.1%
4,4330.0%0.00%
+100.0%
Q1 2022$40,385
-84.9%
4,433
-75.3%
0.00%
-75.0%
Q4 2021$267,277
-45.4%
17,914
-6.0%
0.00%
-42.9%
Q3 2021$489,585
-1.5%
19,0500.0%0.01%0.0%
Q2 2021$496,824
-8.4%
19,050
+24.0%
0.01%
-12.5%
Q1 2021$542,349
+35.7%
15,364
-2.9%
0.01%
+33.3%
Q4 2020$399,524
-32.1%
15,829
+1.5%
0.01%
-40.0%
Q3 2020$588,125
-7.7%
15,596
+4.8%
0.01%
-9.1%
Q2 2020$637,376
+151.6%
14,885
+14.2%
0.01%
+120.0%
Q1 2020$253,284
-25.2%
13,0290.0%0.01%
-16.7%
Q4 2019$338,493
-4.7%
13,0290.0%0.01%0.0%
Q3 2019$355,105
+32.4%
13,029
+30.4%
0.01%
+20.0%
Q2 2019$268,204
+5.9%
9,989
+14.0%
0.01%0.0%
Q1 2019$253,309
+1.6%
8,762
-5.3%
0.01%0.0%
Q4 2018$249,2379,2550.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders